Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010275846 | RD559 T57 2010 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
Musculoskeletal applications of tissue engineering will be among the first to achieve widespread clinical use, and the resulting shift in clinical and surgical paradigms will highlight the need for an authoritative text on tissue engineering for musculoskeletal tissues including nerve, bone, tendon, skin, vessels, and cartilage. This book will serve the needs of a large readership including plastic surgeons, orthopedic surgeons, medical residents and medical students, researchers and academic faculty in regenerative medicine and biomedical engineering, and medical device experts. This textbook will serve as the curriculum for undergraduate and graduate courses in biomedical engineering and surgery. Notable contributors to this volume include Antonios G Mikos, PhD; Wei Liu, MD; Yilin Cao, MD; Mark Randolph, MAS; Jennifer Elisseeff, PhD; Geoffrey C Gurtner, MD; Michael T Longaker, MD; and James Chang, MD, all of whom are leaders in tissue engineering research and applications.
Table of Contents
Acknowledgments | p. v |
Contributors | p. ix |
Chapter 1 Tissue Engineering: A Historical Perspective | p. 1 |
Chapter 2 Current Clinical Needs in Hand Surgery | p. 17 |
Chapter 3 Principles of Tissue Engineering for Reconstruction of the Hand | p. 21 |
Chapter 4 Primary Cell Lines and Stem Cells | p. 41 |
Chapter 5 Scaffolds | p. 65 |
Chapter 6 Animal Models for Engineering Tissues in the Upper Extremity | p. 95 |
Chapter 7 Guidance Strategies in Hand Tissue Engineering: Manipulating the Microenvironment Through Cellular and Material Cues | p. 125 |
Chapter 8 Bioreactors | p. 141 |
Chapter 9 Nerve Engineering | p. 155 |
Chapter 10 Tendon Engineering | p. 171 |
Chapter 11 Skin | p. 195 |
Chapter 12 Bone and Cartilage | p. 219 |
Chapter 13 Blood Vessels | p. 243 |
Chapter 14 Bench to Bedside: Navigating Industry, the FDA and Venture Capital | p. 253 |
Index | p. 269 |